Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.
Decoy Therapeutics has raised $3.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Decoy Therapeutics's investors include Massachusetts Life Sciences Center.
Decoy Therapeutics is headquartered in Cambridge, United States.
Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.
Decoy Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Decoy Therapeutics — Funding & Investors." VCBacked, June 26, 2026, https://www.vcbacked.co/company/decoy-therapeutics. Accessed August 14, 2026.
VCBacked. (2026). Decoy Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/decoy-therapeutics
{{cite web |title=Decoy Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/decoy-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated